|
Tender for Re-Tender For The Procurement Of Anticancer Drugs For The Year 2026-27 , Azathioprine Tab Ip 50 Mg , Cyclophosphamide Tab Ip 50 Mg , Dacarbazine Inj Ip/Usp 200 Mg , Dactinomycin Inj 0.5 Mg/3 Ml , Daunorubicin Inj Ip 20 Mg , Dexamethasone Tab Ip 8 Mg , Dexamethasone Tab Ip 4 Mg , Enzalutamide Cap 80 Mg , Exemestane Tab Ip 25 Mg , Fludarabine Phosphate Inj Ip/ Usp 50 Mg , Ibandronate Tab 50 Mg , Megestrol Acetate Tab Ip/Bp/Usp 40 Mg , Melphalan Tab Ip 5 Mg , Mercaptopurine Tab Ip 50 Mg , Methotrexate Inj (Intrathecal, Preservative Free) 15 Mg , Mitomycin For Inj Ip/Usp 10 Mg , Mitoxantrone Infusion Bp/Usp 20 Mg , Procarbazine Hcl Cap Ip 50 Mg , Rasburicase Inj 1.5 Mg , Regorafenib Tab 40 Mg , Rucaparib Tab 300 Mg , Tegafur +Uracil Cap 100 Mg + 224 Mg , Vinblastine Sulphate Inj Ip 10 Mg , Vincristine Sulphate Inj Ip/Usp 1 Mg , Cisplatin Inj Ip 10 Mg , Cisplatin Inj Ip 50 Mg , Cyclophosphamide Inj Ip 200 Mg , Cyclophosphamide Inj Ip 500 Mg , Cyclophosphamide Inj Ip 1 Gm , Decitabine Inj 50 Mg , Decitabine Inj 30 Mg , Flurouracil Inj Ip 250 Mg , Flurouracil Inj Ip 500 Mg , Ifosfamide With Mesna Inj 1 Gm , Ifosfamide With Mesna Inj 2 Gm , Oxaliplatin Inj Ip 50 Mg , Oxaliplatin Inj Ip 100 Mg , Leucovorin Calcium Inj Ip 15 Mg , Nilotinib Cap 200 Mg , Nilotinib Cap 150 Mg
|
